Last Updated: May 14, 2026

CLINICAL TRIALS PROFILE FOR ORLYNVAH


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ORLYNVAH

Trial ID Title Status Sponsor Phase Start Date Summary
NCT07092813 ↗ Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents NOT_YET_RECRUITING Iterum Therapeutics, International Limited PHASE1 2025-09-01 The goal of this clinical trial is to evaluate the use of sulopenem etzadroxil plus probenecid in adolescent patients being treated for bacterial infection. The main questions it aims to answer are: Is sulopenem etzadroxil plus probenecid safe to use in adolescents? Is sulopenem etzadroxil plus probenecid tolerable when used in adolescents? When ingested, what does the adolescent body do to sulopenem etzadroxil plus probenecid, in terms of the movement of the drug into, through, and out of the body. Participants will receive standard of care antibiotics for their bacterial infection as directed by their physician. In addition, participants will be asked to take a single oral dose of sulopenem etzadroxil plus probenecid. Blood samples will be collected before the dose of sulopenem etzadroxil plus probenecid, as well as at specified timepoints after the dose. Likewise, urine will be collected at specified time periods after the dose. During the course of the study, data will be collected from participants including vital sign measurements, physical examination findings, and the details of any adverse events that are reported.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ORLYNVAH

Condition Name

Condition Name for ORLYNVAH
Intervention Trials
Pharmacokinetics After Oral Intake 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ORLYNVAH
Intervention Trials
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ORLYNVAH

Clinical Trial Phase

Clinical Trial Phase for ORLYNVAH
Clinical Trial Phase Trials
PHASE1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ORLYNVAH
Clinical Trial Phase Trials
NOT_YET_RECRUITING 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ORLYNVAH

Sponsor Name

Sponsor Name for ORLYNVAH
Sponsor Trials
Iterum Therapeutics, International Limited 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ORLYNVAH
Sponsor Trials
INDUSTRY 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.